HumanInc Revenue and Competitors

Kuala Lumpur,

Location

N/A

Total Funding

Design

Industry

Estimated Revenue & Valuation

  • HumanInc's estimated annual revenue is currently $8.9M per year.(i)
  • HumanInc's estimated revenue per employee is $194,400

Employee Data

  • HumanInc has 46 Employees.(i)
  • HumanInc grew their employee count by 10% last year.

HumanInc's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$29.4M121-42%N/AN/A
#2
$12M558%N/AN/A
#3
$29.6M122-2%N/AN/A
#4
$12.5M5716%N/AN/A
#5
$14.9M68-19%N/AN/A
#6
$9.7M50-4%N/AN/A
#7
$24.8M10226%N/AN/A
#8
$20.9M869%N/AN/A
#9
$13.8M63-7%N/AN/A
#10
$13.6M62-21%N/AN/A
Add Company

What Is HumanInc?

We are Human Inc! We help large organisations grow by building Future-Ready Humans and driving Growth through Innovation. We do this through fun, impactful and relevant engagements focused on future-proofing talent, boosting customer experiences and transforming organisational culture. Our ways of working is informed by a range of practices including design thinking, agile and positive psychology. We facilitate engaging workshops tailored to your audiences to build future skills in all levels of the organisation, and/or co-create solutions through our modules, which can range from a short keynote to a 12 month capacity development programme in areas of: - Design Thinking - Solution Design Labs - Strategic Change - Growth Mindset - Culture - Agile Teams Get in touch with us through +60392129410 and learn@humaninc.co Visit our website www.humaninc.co to learn more

keywords:N/A

N/A

Total Funding

46

Number of Employees

$8.9M

Revenue (est)

10%

Employee Growth %

N/A

Valuation

N/A

Accelerator

HumanInc News

2022-04-06 - Sampling Human Raises $2 Million to Support the ...

Sampling Human, Inc. is a synthetic biology diagnostics company developing novel methods for the early detection of disease.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.7M465%N/A
#2
$8.9M494%N/A
#3
$5.7M49N/AN/A
#4
$5.8M50-11%N/A
#5
$11.3M6015%N/A